Westchester Capital Management (Nebraska)’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
VF
Westchester Capital Management (Nebraska)'s MDT Position: Q2 2026 in Review
Westchester Capital Management (Nebraska) reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $172K and leaving 99,190 shares worth $7.76M. The position accounts for 1.4% of the portfolio, ranked #21.
Westchester Capital Management (Nebraska) first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.3M in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Westchester Capital Management (Nebraska) held 99,190 shares of Medtronic worth $7.76M as of Q2 2026.
- Westchester Capital Management (Nebraska) sold 2,132 Medtronic shares in Q2 2026, an estimated $172K.
- Medtronic made up 1.4% of Westchester Capital Management (Nebraska)'s portfolio in Q2 2026, its #21 holding.
- Westchester Capital Management (Nebraska) first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
- Westchester Capital Management (Nebraska)'s Medtronic position peaked at $10.3M in Q3 2021.
- 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Westchester Capital Management (Nebraska)'s 13F filing for Q2 2026, filed 23 Jul 2026.